SCHEMBL10035638

SCHEMBL10035638

COc1cc2c(cc1OC)CN(CCCNS(=O)(=O)c1ccc3[nH]c(=O)sc3c1)CC2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.48
POLB P06746 1/20 0.48
ABCB1 P08183 2/20 0.46
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD2 P14416 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR6 P50406 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44
PKM P14618 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
GFER P55789 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2141426 0.99 HTR7 (0.48) HTR7POLBABCB1HTR1AADRA2A
SCHEMBL10035598 0.84 POLB (0.62) HTR7POLBABCB1DRD2LMNA
SCHEMBL8983715 0.84 HTR7 (0.66) HTR7HTR1AHTR6ALDH1A1LMNA
SCHEMBL2138249 0.83 ALPL (0.54) HTR7POLBKMT2A
Hydrochloric Acid SCHEMBL2138910 0.83 POLB (0.61) HTR7POLBABCB1DRD2LMNA
SCHEMBL10035645 0.81 HTR7 (0.55) HTR7POLBABCB1ALDH1A1MEN1
SCHEMBL8982167 0.81 HTR7 (0.59) HTR7POLBABCB1HTR6LMNA
SCHEMBL10035595 0.81 ABCB1 (0.64) HTR7ABCB1HTR1AHTR2AHTR2C
SCHEMBL10035624 0.81 MBTD1 (0.59) HTR7ABCB1HTR1ADRD2HTR2A
SCHEMBL2138032 0.81 HTR7 (0.57) HTR7POLBABCB1TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148397-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-04-03 US disclosed
US-8148397-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-04-03 US disclosed
US-20090088450-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-04-02 US disclosed
US-20090088450-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088450-A1 5-ht7 receptor antagonists HTR7, HTR1A, HTR5A HTR7 1/4885POLB 3250/4885ABCB1 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.